Our work is built around execution. We help define data needs, structure workflows, develop models, test performance, refine results, and translate technical progress into usable outputs for the startup team.

Our collaboration model is intentional. Depending on the stage and needs of each startup, OY BioSystems may work through equity-based, deferred-fee, or hybrid structures designed to reduce upfront barriers to technical development while giving early-stage teams access to computational and AI support before they are ready to build a full internal technical team or take on traditional upfront costs.

Our model aligns our work with the progress of the startups we support. That means we prioritize clear communication, collaboration, and technical rigor at every stage, working closely with teams to understand their needs, adapt as goals evolve, and deliver reliable outcomes.

We also aim to create meaningful technical opportunities for early-career builders who want to apply artificial intelligence, machine learning, and computational methods to real bioengineering, biotech, medtech, and healthtech challenges.